|
1
|
Younger EM and Chapman MW: Morbidity at
bone graft donor sites. J Orthop Trauma. 3:192–195. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banwart JC, Asher MA and Hassanein RS:
Iliac crest bone graft harvest donor site morbidity. A statistical
evaluation. Spine (Phila Pa 1976). 20:1055–1060. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang C, Meng G, Zhang L, Xiong Z and Liu
J: Physical properties and biocompatibility of a core-sheath
structure composite scaffold for bone tissue engineering in vitro.
J Biomed Biotechnol. 2012:5791412012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie H, Wang Z, Zhang L, Lei Q, Zhao A,
Wang H, Li Q, Chen Z and Zhang W: Development of an
angiogenesis-promoting microvesicle-alginate-polycaprolactone
composite graft for bone tissue engineering applications. PeerJ.
4:e20402016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu W, Le AV, Mendez JJ, Chang J, Niklason
LE and Steinbacher DM: Osteogenic performance of donor-matched
human adipose and bone marrow mesenchymal cells under dynamic
culture. Tissue engineering. Part A. 21:1621–1632. 2015.
|
|
6
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Girolamo L, Lucarelli E, Alessandri G,
Avanzini MA, Bernardo ME, Biagi E, Brini AT, D'Amico G, Fagioli F,
Ferrero I, et al: Mesenchymal stem/stromal cells: A new ‘cells as
drugs’ paradigm. Efficacy and critical aspects in cell therapy.
Curr Pharm Des. 19:2459–2473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prockop DJ: Marrow stromal cells as stem
cells for nonhematopoietic tissues. Science. 276:71–74. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Egashira K, Sumita Y, Zhong W, Ohba S,
Nagai K and Asahina I: Bone marrow concentrate promotes bone
regeneration with a suboptimal-dose of rhBMP-2. PLoS One.
13:e01910992018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hokugo A, Saito T, Li A, Sato K, Tabata Y
and Jarrahy R: Stimulation of bone regeneration following the
controlled release of water-insoluble oxysterol from biodegradable
hydrogel. Biomaterials. 35:5565–5571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Atesok K, Li R, Stewart DJ and Schemitsch
EH: Endothelial progenitor cells promote fracture healing in a
segmental bone defect model. J Orthop Res. 28:1007–1014.
2010.PubMed/NCBI
|
|
12
|
Shirota T, Yasui H, Shimokawa H and
Matsuda T: Fabrication of endothelial progenitor cell (EPC)-seeded
intravascular stent devices and in vitro endothelialization on
hybrid vascular tissue. Biomaterials. 24:2295–2302. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li R, Atesok K, Nauth A, Wright D,
Qamirani E, Whyne CM and Schemitsch EH: Endothelial progenitor
cells for fracture healing: A microcomputed tomography and
biomechanical analysis. J Orthop Trauma. 25:467–471. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seebach C, Henrich D, Kähling C, Wilhelm
K, Tami AE, Alini M and Marzi I: Endothelial progenitor cells and
mesenchymal stem cells seeded onto beta-TCP granules enhance early
vascularization and bone healing in a critical-sized bone defect in
rats. Tissue Eng Part A. 16:1961–1970. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carreira AC, Lojudice FH, Halcsik E,
Navarro RD, Sogayar MC and Granjeiro JM: Bone morphogenetic
proteins: Facts, challenges, and future perspectives. J Dent Res.
93:335–345. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ho SS, Vollmer NL, Refaat MI, Jeon O,
Alsberg E, Lee MA and Leach JK: Bone morphogenetic protein-2
promotes human mesenchymal stem cell survival and resultant bone
formation when entrapped in photocrosslinked alginate hydrogels.
Adv Healthc Mater. 5:2501–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carreira AC, Zambuzzi WF, Rossi MC,
Astorino Filho R, Sogayar MC and Granjeiro JM: Bone morphogenetic
proteins: Promising molecules for bone healing, bioengineering, and
regenerative medicine. Vitam Horm. 99:293–322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garrison KR, Donell S, Ryder J, Shemilt I,
Mugford M, Harvey I and Song F: Clinical effectiveness and
cost-effectiveness of bone morphogenetic proteins in the
non-healing of fractures and spinal fusion: A systematic review.
Health Technol Assess. 11:1–150, iii-iv. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bloomsmith MA, Perlman JE, Hutchinson E
and Sharpless M: Behavioral management programs to promote
laboratory animal welfareManagement of animal care and use programs
in research, education, and testing. Weichbrod RH, Thompson GAH and
Norton JN: 2nd. CRC Press/Taylor & Francis; Boca Raton, FL:
2018
|
|
20
|
He X, Dziak R, Yuan X, Mao K, Genco R,
Swihart M, Sarkar D, Li C, Wang C, Lu L, et al: BMP2 genetically
engineered MSCs and EPCs promote vascularized bone regeneration in
rat critical-sized calvarial bone defects. PLoS One. 8:e604732013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amstein CF and Hartman PA: Adaptation of
plastic surfaces for tissue culture by glow discharge. J Clin
Microbiol. 2:46–54. 1975.PubMed/NCBI
|
|
23
|
Shi S, Wang XH, Guo G, Fan M, Huang MJ and
Qian ZY: Preparation and characterization of microporous
poly(D,L-lactic acid) film for tissue engineering scaffold. Int J
Nanomedicine. 5:1049–1055. 2010.PubMed/NCBI
|
|
24
|
Alghazali KM, Nima ZA, Hamzah RN, Dhar MS,
Anderson DE and Biris AS: Bone-tissue engineering: Complex tunable
structural and biological responses to injury, drug delivery, and
cell-based therapies. Drug Metab Rev. 47:431–454. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
An ideal cell source for bone tissue
engineering? Bonekey Rep. 1:2222012.PubMed/NCBI
|
|
26
|
Sun J, Li J, Li C and Yu Y: Role of bone
morphogenetic protein-2 in osteogenic differentiation of
mesenchymal stem cells. Mol Med Rep. 12:4230–4237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smajilagić A, Aljičević M, Redžić A,
Filipović S and Lagumdžija A: Rat bone marrow stem cells isolation
and culture as a bone formative experimental system. Bosn J Basic
Med Sci. 13:27–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Denecke B, Horsch LD, Radtke S, Fischer
JC, Horn PA and Giebel B: Human endothelial colony-forming cells
expanded with an improved protocol are a useful endothelial cell
source for scaffold-based tissue engineering. J Tissue Eng Regen
Med. 9:E84–E97. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kalka C, Masuda H, Takahashi T, Kalka-Moll
WM, Silver M, Kearney M, Li T, Isner JM and Asahara T:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
James AW, LaChaud G, Shen J, Asatrian G,
Nguyen V, Zhang X, Ting K and Soo C: A review of the clinical side
effects of bone morphogenetic protein-2. Tissue Eng Part B Rev.
22:284–297. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo X, Chen J, Song WX, Tang N, Luo J,
Deng ZL, Sharff KA, He G, Bi Y, He BC, et al: Osteogenic BMPs
promote tumor growth of human osteosarcomas that harbor
differentiation defects. Lab Invest. 88:1264–1277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen D, Zhao M and Mundy GR: Bone
morphogenetic proteins. Growth Factors. 22:233–241. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fan T, Chen J, Pan P, Zhang Y, Hu Y, Liu
X, Shi X and Zhang Q: Bioinspired double polysaccharides-based
nanohybrid scaffold for bone tissue engineering. Colloids Surf B
Biointerfaces. 147:217–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z,
Zhang Y, Li Y, Mao Q, Wang J, et al: An inactivated enterovirus 71
vaccine in healthy children. N Engl J Med. 370:829–837. 2014.
View Article : Google Scholar : PubMed/NCBI
|
